Skip to main content
. Author manuscript; available in PMC: 2021 Dec 28.
Published in final edited form as: Sci Transl Med. 2021 Jan 13;13(576):eabc6245. doi: 10.1126/scitranslmed.abc6245

Table 1. NS physical properties.

P4, TSA, and SAHA NS formulations and sizes. Particles were formulated via wet milling (10 hours) in Pluronic F127. Size, PDI, and ζ-potential are represented as means ± SD (n ≥ 3).

Drug concentration % F127 (w/v) Beads type-mass (g) Tube size (ml) Size (nm) PDI ζ-Potential (mV)
P4 (5 mg/ml) 2 ZROB05 (1.5) 2.0 346.4 ± 15.8 0.11 ± 0.07 −1.08 ± 0.84
P4 (25 mg/ml) 2 ZROB05 (2.4) 2.0 302.5 ± 9.7 0.17 ± 0.02 −1.59 ± 0.21
P4 (50 mg/ml) 2 ZROB05 (2.4) 2.0 305.9 ± 5.8 0.21 ± 0.15 −0.087 ± 0.012
P4 (80 mg/ml) 2 ZROB05 (2.4) 2.0 376.7 ± 14.1 0.19 ± 0.12 −0.92 ± 0.72
P4 (250 mg/ml) 6 ZROB05 (3.5) 2.0 315.5 ± 7.9 0.17 ± 0.06 −1.48 ± 0.17
TSA (1.5 mg/ml) 4 ZSB05 (1.5) 1.5 215.9 ± 12.9 0.12 ± 0.07 −0.06 ± 0.04
SAHA (1.5 mg/ml) 4 ZROB05 (1.5) 1.5 263.5 ± 48.6 0.37 ± 0.24 −2.44 ± 0.89